X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (593) 593
Publication (96) 96
Newspaper Article (27) 27
Book Chapter (9) 9
Newsletter (9) 9
Book Review (7) 7
Magazine Article (2) 2
Conference Proceeding (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
rilpivirine (543) 543
humans (370) 370
index medicus (353) 353
hiv infections - drug therapy (250) 250
infectious diseases (206) 206
hiv (190) 190
pharmacology & pharmacy (182) 182
efavirenz (173) 173
hiv-1 - drug effects (157) 157
female (146) 146
male (146) 146
anti-hiv agents - therapeutic use (130) 130
adult (128) 128
hiv infections - virology (120) 120
emtricitabine (112) 112
immunology (112) 112
antiretroviral therapy (109) 109
anti-hiv agents - administration & dosage (108) 108
tenofovir (106) 106
anti-hiv agents - pharmacology (104) 104
antiviral agents (101) 101
microbiology (101) 101
middle aged (99) 99
drug therapy (90) 90
hiv-1 (90) 90
human immunodeficiency virus--hiv (90) 90
pharmacokinetics (88) 88
hiv infection (87) 87
antiretroviral drugs (83) 83
pyrimidines - therapeutic use (82) 82
nitriles - therapeutic use (81) 81
hiv-1 - genetics (80) 80
safety (78) 78
reverse transcriptase inhibitors - pharmacology (76) 76
drug resistance, viral (73) 73
pyrimidines - pharmacology (72) 72
etravirine (71) 71
hiv reverse transcriptase - antagonists & inhibitors (71) 71
treatment outcome (70) 70
double-blind (69) 69
mutation (69) 69
reverse transcriptase inhibitors - therapeutic use (68) 68
virology (68) 68
anti-hiv agents - adverse effects (67) 67
phase-3 (65) 65
aids/hiv (64) 64
nitriles - pharmacology (62) 62
analysis (61) 61
dosage and administration (61) 61
viral load (61) 61
young adult (58) 58
infection (56) 56
nitriles - administration & dosage (56) 56
pyrimidines - administration & dosage (56) 56
reverse-transcriptase inhibitors (55) 55
rilpivirine - therapeutic use (55) 55
efficacy (54) 54
nitriles - adverse effects (54) 54
pyrimidines - adverse effects (54) 54
therapy (54) 54
trial (50) 50
dolutegravir (49) 49
drug resistance (48) 48
health aspects (48) 48
adults (47) 47
drug combinations (47) 47
immunodeficiency-virus type-1 (47) 47
research (47) 47
clinical trials (46) 46
drug-resistance (46) 46
resistance (46) 46
drug therapy, combination (45) 45
drug interactions (44) 44
hiv-1-infected patients (43) 43
rilpivirine - administration & dosage (43) 43
tmc278 (43) 43
anti-hiv agents - pharmacokinetics (42) 42
hiv reverse transcriptase - genetics (42) 42
nevirapine (42) 42
drug resistance, viral - genetics (41) 41
drugs (41) 41
reverse transcriptase inhibitors - chemistry (41) 41
adenine - analogs & derivatives (40) 40
adolescent (37) 37
dna polymerases (37) 37
hiv reverse transcriptase - metabolism (37) 37
hiv-1 - enzymology (37) 37
hiv-1 - isolation & purification (37) 37
virus diseases (37) 37
animals (36) 36
article (36) 36
chemistry, medicinal (36) 36
deoxycytidine - analogs & derivatives (35) 35
pyrimidines - chemistry (35) 35
pyrimidines - pharmacokinetics (35) 35
nitriles - pharmacokinetics (34) 34
aids (33) 33
benzoxazines - therapeutic use (33) 33
non-nucleoside reverse transcriptase inhibitors (33) 33
protease inhibitors (33) 33
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (611) 611
Spanish (16) 16
German (5) 5
Czech (2) 2
French (2) 2
Chinese (1) 1
Japanese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Medecine et Maladies Infectieuses, ISSN 0399-077X, 06/2019, Volume 49, Issue 4, p. S144
L'allegement par bitherapie de DTG (Dolutegravir)-RPV (Rilpivirine) est reconnu comme une alternative en deuxieme ligne de traitement chez un PVVIH sans... 
Rilpivirine
Journal Article
American Journal of Health-System Pharmacy, ISSN 1079-2082, 05/2012, Volume 69, Issue 10, p. 857
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 2 - 12
Journal Article
Lancet HIV, The, ISSN 2352-3018, 2016, Volume 3, Issue 12, pp. e569 - e578
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, p. e0134430
Objective To assess, in a clinical cohort, the efficacy of switching treatment in virologically-suppressed patients to tenofovir/emtricitabine/rilpivirine as a... 
MULTIDISCIPLINARY SCIENCES | DISOPROXIL FUMARATE | EMTRICITABINE | SINGLE-TABLET REGIMEN | RILPIVIRINE | RPV/TDF/FTC | TENOFOVIR | Tenofovir - blood | Follow-Up Studies | Humans | Middle Aged | Emtricitabine, Rilpivirine, Tenofovir Drug Combination - therapeutic use | Male | Tenofovir - administration & dosage | Anti-HIV Agents - administration & dosage | Rilpivirine - therapeutic use | Rilpivirine - blood | Adult | Anti-HIV Agents - therapeutic use | Female | Anti-HIV Agents - blood | Drug Therapy, Combination | Rilpivirine - administration & dosage | Emtricitabine - administration & dosage | Emtricitabine - therapeutic use | Tenofovir - therapeutic use | Emtricitabine, Rilpivirine, Tenofovir Drug Combination - administration & dosage | Emtricitabine - blood | HIV Infections - drug therapy | Drug Substitution | Viral Load - drug effects | Drug Combinations | Virus diseases | Highly active antiretroviral therapy | Care and treatment | Protease inhibitors | Proteases | DNA polymerases | Health aspects | Emtricitabine | Antiretroviral drugs | RNA-directed DNA polymerase | Viremia | Viruses | Proteinase inhibitors | Signal monitoring | Patients | Switching | Chromatography | Antiretroviral therapy | Tenofovir | Non-nucleoside reverse transcriptase inhibitors | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Scientific imaging | Drug therapy | Mass spectrometry | Drug dosages | Genotypes | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 07/2017, Volume 17, Issue 1, pp. 476 - 10
Journal Article
Journal Article
Science, ISSN 0036-8075, 07/2019, Volume 365, Issue 6451, p. 309
Journal Article
Journal Article
Journal Article